MicroTransponder Names Frank McEachern as Executive Chairman of the Board

Dallas, TX, July 15, 2009 --(PR.com)-- MicroTransponder Inc., a privately held medical device company developing a suite of wireless neuroneuroprosthesis, has just announced the promotion of Frank McEachern to Executive Chairman of the Board. “As one of the founding members of the Company, McEachern has been an integral part of the company's success. His intellectual leadership and thorough legal diligence has allowed our Company to enter successful partnerships with many different organizations,” stated CEO Will Rosellini. In his capacity as CFO and General Counsel, McEachern has been the architect of several innovative transactions. One example is the development agreement with the University of Texas of Dallas, which has become the cornerstone of the extensive neuroprosthesis research program led by MicroTransponder.

McEachern continues to manage the daily financial and legal aspects for the Company, guiding operations through the complex regulatory, intellectual property and financial environment for a Class II/ III medical device. Prior to joining MicroTransponder, McEachern earned his undergraduate degrees in finance and business from the University of Texas Business Honors program and went on to earn a JD with honors from UT Law. He then worked as a transaction attorney for Baker Botts in their corporate division and was on the deal team for Advanced Neuromodulation Systems in Plano, when they were acquired by St. Jude Medical. Recently, McEachern was the chief architect of MicroTransponder's $2.2M Series A financing round and worked with engineers to transfer the animal prototype under design controls to a virtual supply chain of GMP manufacturers. McEachern attended Dallas Jesuit for high school where he became close friends with Will Rosellini and Jordan Curnes, the Company's current CEO and current President. "Working in partnership with long term friends has been a great blessing in my life - a once in a lifetime opportunity. I believe this is why we have been successful." McEachern explained.

About MicroTransponder, Inc.
MicroTransponder ( www.microtransponder.com) is developing a wireless neurostimulation system for the treatment of chronic pain and several other neurological indications. The minimally invasive device will provide relief from chronic pain without requiring an implanted battery or wires. The Company is finalizing device R&D and accumulating data toward FDA clearance. MicroTransponder is also adapting our system for Vagus Nerve Stimulation to create a pipeline of innovative treatments for other neurological indications, including stroke rehabilitation, tinnitus, and autism.

###